Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1

Overview

Journal Cancer Res

Specialty Oncology

Date 2016 Mar 17

PMID 26980762

Citations 16

Authors

Xiaoying Zhang

Cai Guo

Xiwei Wu

Arthur X Li

Limin Liu

Walter Tsark

Reinhard Dammann

Hui Shen

Steven L Vonderfecht

Gerd P Pfeifer

Affiliations

Soon will be listed here.

Abstract

The tumor suppressor gene RASSF1A is epigenetically silenced in most human cancers. As a binding partner of the kinases MST1 and MST2, the mammalian orthologs of the Drosophila Hippo kinase, RASSF1A is a potential regulator of the Hippo tumor suppressor pathway. RASSF1A shares these properties with the scaffold protein SAV1. The role of this pathway in human cancer has remained enigmatic inasmuch as Hippo pathway components are rarely mutated in tumors. Here we show that Rassf1a homozygous knockout mice develop liver tumors. However, heterozygous deletion of Sav1 or codeletion of Rassf1a and Sav1 produced liver tumors with much higher efficiency than single deletion of Rassf1a. Analysis of RASSF1A-binding partners by mass spectrometry identified the Hippo kinases MST1, MST2, and the oncogenic IκB kinase TBK1 as the most enriched RASSF1A-interacting proteins. The transcriptome of Rassf1a(-/-) livers was more deregulated than that of Sav1(+/-) livers, and the transcriptome of Rassf1a(-/-), Sav1(+/-) livers was similar to that of Rassf1a(-/-) mice. We found that the levels of TBK1 protein were substantially upregulated in livers lacking Rassf1a. Furthermore, transcripts of several β-tubulin isoforms were increased in the Rassf1a-deficient livers presumably reflecting a role of RASSF1A as a microtubule-stabilizing protein. In human liver cancer, RASSF1A frequently undergoes methylation at the promoter but this was not observed for MST1, MST2, or SAV1. Our results suggest a multifactorial role of RASSF1A in suppression of liver carcinogenesis. Cancer Res; 76(9); 2824-35. ©2016 AACR.

Citing Articles

Impaired Expression of the Salvador Homolog-1 Gene Is Associated with the Development and Progression of Colorectal Cancer.

Kowalczyk A, Krazinski B, Piotrowska A, Grzegrzolka J, Godlewski J, Dziegiel P Cancers (Basel). 2023; 15(24).

PMID: 38136317 PMC: 10742029. DOI: 10.3390/cancers15245771.

RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues.

Scheiter A, Evert K, Reibenspies L, Cigliano A, Annweiler K, Muller K Mol Oncol. 2021; 16(5):1091-1118.

PMID: 34748271 PMC: 8895452. DOI: 10.1002/1878-0261.13135.

The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle.

de Amorim I, de Sousa Rodrigues M, Mencalha A J Cancer Res Clin Oncol. 2021; 147(5):1287-1297.

PMID: 33580421 DOI: 10.1007/s00432-021-03552-3.

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review.

Dubois F, Bergot E, Zalcman G, Levallet G Cell Death Dis. 2019; 10(12):928.

PMID: 31804463 PMC: 6895193. DOI: 10.1038/s41419-019-2169-x.

Methylation Dynamics of and Its Impact on Cancer.

Malpeli G, Innamorati G, Decimo I, Bencivenga M, Nwabo Kamdje A, Perris R Cancers (Basel). 2019; 11(7).

PMID: 31323949 PMC: 6678546. DOI: 10.3390/cancers11070959.

References

Tang S, Silva F, Tsark W, Mann J . A Cre/loxP-deleter transgenic line in mouse strain 129S1/SvImJ. Genesis. 2002; 32(3):199-202. DOI: 10.1002/gene.10030. View

Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A . Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell. 2015; 162(4):766-79. PMC: 4545590. DOI: 10.1016/j.cell.2015.07.026. View

Zhang Y, Ahsan H, Chen Y, Lunn R, Wang L, Chen S . High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol Carcinog. 2002; 35(2):85-92. DOI: 10.1002/mc.10076. View

Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe H, Pfeifer G . Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene. 2003; 22(12):1866-71. DOI: 10.1038/sj.onc.1206338. View

Zhong S, Yeo W, Tang M, Wong N, Lai P, Johnson P . Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res. 2003; 9(9):3376-82. View

Udan R, Kango-Singh M, Nolo R, Tao C, Halder G . Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003; 5(10):914-20. DOI: 10.1038/ncb1050. View

Dallol A, Agathanggelou A, Tommasi S, Pfeifer G, Maher E, Latif F . Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res. 2005; 65(17):7653-9. DOI: 10.1158/0008-5472.CAN-05-0247. View

Liu L, Tommasi S, Lee D, Dammann R, Pfeifer G . Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene. 2003; 22(50):8125-36. DOI: 10.1038/sj.onc.1206984. View

Dallol A, Agathanggelou A, Fenton S, Ahmed-Choudhury J, Hesson L, Vos M . RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res. 2004; 64(12):4112-6. DOI: 10.1158/0008-5472.CAN-04-0267. View

10.

Vos M, Martinez A, Elam C, Dallol A, Taylor B, Latif F . A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 2004; 64(12):4244-50. DOI: 10.1158/0008-5472.CAN-04-0339. View

11.

Xiong Z, Laird P . COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997; 25(12):2532-4. PMC: 146738. DOI: 10.1093/nar/25.12.2532. View

12.

Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark W . Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 2005; 65(1):92-8. View

13.

Agathanggelou A, Cooper W, Latif F . Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 2005; 65(9):3497-508. DOI: 10.1158/0008-5472.CAN-04-4088. View

14.

Huang J, Wu S, Barrera J, Matthews K, Pan D . The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005; 122(3):421-34. DOI: 10.1016/j.cell.2005.06.007. View

15.

van der Weyden L, Tachibana K, Gonzalez M, Adams D, Ng B, Petty R . The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol. 2005; 25(18):8356-67. PMC: 1234312. DOI: 10.1128/MCB.25.18.8356-8367.2005. View

16.

Dammann R, Li C, Yoon J, Chin P, Bates S, Pfeifer G . Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000; 25(3):315-9. DOI: 10.1038/77083. View

17.

Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M . Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 2000; 19(18):4976-85. PMC: 314216. DOI: 10.1093/emboj/19.18.4976. View

18.

Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang X, Dammann R, Pfeifer G . The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene. 2002; 21(9):1381-90. DOI: 10.1038/sj.onc.1205192. View

19.

Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang X . Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol. 2002; 12(4):253-65. DOI: 10.1016/s0960-9822(02)00683-8. View

20.

Zender L, Spector M, Xue W, Flemming P, Cordon-Cardo C, Silke J . Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006; 125(7):1253-67. PMC: 3026384. DOI: 10.1016/j.cell.2006.05.030. View